Last checked at 23 Oct 2014 15:19
23 October 2014
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Annual Report and Accounts
Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company, announces that the Annual Report and Accounts of the Company for the year ended 30 June 2014 and Notice of Annual General Meeting have been posted to shareholders.
The Annual Report and Accounts and Notice of the Annual General Meeting are available on the Company's website in the Investor Relations section. They can be located at http://www.allergytherapeutics.com/Reports%20and%20Presentations%20Sub.aspx for the Annual Report and Accounts and http://www.allergytherapeutics.com/AGM.aspx for the Notice of the Meeting.
For further information
Allergy Therapeutics | +44 (0) 1903 845 820 |
Manuel Llobet, Chief Executive Officer Ian Postlethwaite, Finance Director |
|
Peel Hunt LLP | +44 (0) 20 7418 8900 |
James Steel Clare Terlouw |
|
FTI Consulting | +44 (0) 20 3727 1000 |
Simon Conway Victoria Foster Mitchell |
|
Notes to editors
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of £42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging Markets.